Credit crisis advantage?

[Joelle]

Credit crisis advantage?
      

The credit crisis may just be the leverage Roche needs in its bid for Genentech.
The Swiss drug maker went hostile with its bid to buy the 44 percent of Genentech it doesn’t already own. But in a rather unusual move, it has gone to shareholders with an offer that is actually lower than the $44 [...]
         

You are not allowed to view links. Register or Login